Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-16-097072
Filing Date
2016-04-28
Accepted
2016-04-28 16:06:27
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v438082_10ka.htm 10-K/A 25596
2 EXHIBIT 23.01 v438082_ex23-01.htm EX-23.01 2523
3 EXHIBIT 31.01 v438082_ex31-01.htm EX-31.01 4338
4 EXHIBIT 31.02 v438082_ex31-02.htm EX-31.02 4197
  Complete submission text file 0001144204-16-097072.txt   37767
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36019 | Film No.: 161600059
SIC: 2834 Pharmaceutical Preparations